This approval represents a significant regulatory milestone, making Prolivâ„¢Rx the first and only at-home neuromodulation ...
After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback